Update on lipid management: commonly asked questions

Hamilton-Craig, I

View/Open

78652_1.pdf (1.449Mb)

Author(s)

Hamilton-Craig, I

Griffith University Author(s)

Hamilton-Craig, Ian

Year published

2012

Metadata

Show full item record

Abstract

LDL-cholesterol (LDL-C) target levels in patients with cardiovascular disease (CVD) are getting lower. New statin combinations will be more cost effective than present combinations and will help to achieve LDL-C targets. These and other drugs in development promise a new era in CVD prevention.LDL-cholesterol (LDL-C) target levels in patients with cardiovascular disease (CVD) are getting lower. New statin combinations will be more cost effective than present combinations and will help to achieve LDL-C targets. These and other drugs in development promise a new era in CVD prevention.
View less >

Journal Title

Medicine Today

Volume

Issue

Publisher URI

https://medicinetoday.com.au/mt/january-2012

Copyright Statement

Subject

Biomedical and clinical sciences

Publication URI

http://hdl.handle.net/10072/49291

Collection

Journal articles